UC Davis Health Ventures will make an investment in Delix Therapeutics Inc., which has licensed UC Davis technology to develop non-hallucinogenic neuroplastogens as novel treatments for depression and ...
The Fund seeks as high a level of current income exempts from federal income tax and from Pennsylvania state personal income tax as is consistent with preservation of capital. The Fund will invest at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results